Antidepressant‐like effect of low dose of scopolamine in the H/Rouen genetic mouse model of depression - Archive ouverte HAL Access content directly
Journal Articles Fundamental & Clinical Pharmacology Year : 2020

Antidepressant‐like effect of low dose of scopolamine in the H/Rouen genetic mouse model of depression

(1) , (2) , (1)
1
2

Abstract

Rodent models of depression are useful for the investigation of cellular and neuronal mechanisms of antidepressant drugs and for the discovery of potential new targets. In this study, we examined the antidepressant-like effect of scopolamine, a non-selective muscarinic antagonist, in a genetic mouse model of depression obtained through a selective breeding strategy and called H/Rouen. In this model, we observed that scopolamine was active both in males and females at a lower dose (0.03 mg/kg) in the tail suspension test, 30 min following its administration, than observed in CD-1 mice. In addition, we showed this antidepressant-like effect was partly inhibited by an injection of 10 mg/kg of the AMPA receptor antagonist NBQX in both males and females, suggesting the anti-depressant like effect of scopolamine was mainly driven by AMPA receptors in the H/Rouen mouse line. Altogether, our results showed the high sensitivity of the H/Rouen mouse model of depression to study the antidepressant-like effects of pharmacological compounds.
Fichier principal
Vignette du fichier
Scopolamine_FCP_revision_20201111.pdf (169.51 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

inserm-03198220 , version 1 (14-04-2021)

Identifiers

Cite

Malika El Yacoubi, Jean-Marie Vaugeois, Stéphane Jamain. Antidepressant‐like effect of low dose of scopolamine in the H/Rouen genetic mouse model of depression. Fundamental & Clinical Pharmacology, 2020, Online ahead of print. ⟨10.1111/fcp.12639⟩. ⟨inserm-03198220⟩
105 View
86 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More